MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-022-13527-0

Медицинская библиотека · Scientific reports · 2022

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis.

Ejemel Monir, Smith Todd G, Greenberg Lauren, Carson William C, Lowe David, Yang Yong, Jackson Felix R, Morgan Clint N, Martin Brock E, Kling Chantal, Hutson Christina L, Gallardo-Romero Nadia, Ellison James A, Moore Susan, Buzby Adam, Sullivan-Bolyai John, Klempner Mark, Wang Yang

СтатьяПеревод в очереди

Аннотация

Human rabies remains a globally significant public health problem. Replacement of polyclonal anti-rabies immunoglobulin (RIG), a passive component of rabies post-exposure prophylaxis (PEP), with a monoclonal antibody (MAb), would eliminate the cost and availability constraints associated with RIG. Our team has developed and licensed a human monoclonal antibody RAB1 (Rabishield©), as the replacement for RIG where canine rabies is enzootic. However, for the highly diverse rabies viruses of North America, a cocktail containing two or more MAbs targeting different antigenic sites of the rabies glycoprotein should be included to ensure neutralization of all variants of the virus. In this study, two MAb cocktails, R172 (RAB1-RAB2) and R173 (RAB1-CR57), were identified and evaluated against a broad range of rabies variants from North America. R173 was found to be the most potent cocktail, as it neutralized all the tested North American RABV isolates and demonstrated broad coverage of isolates from both terrestrial and bat species. R173 could be a promising candidate as an alternative or replacement for RIG PEP in North America.

Для цитирования: Ejemel Monir, Smith Todd G, Greenberg Lauren, Carson William C, Lowe David, Yang Yong, Jackson Felix R, Morgan Clint N, Martin Brock E, Kling Chantal, Hutson Christina L, Gallardo-Romero Nadia, Ellison James A, Moore Susan, Buzby Adam, Sullivan-Bolyai John, Klempner Mark, Wang Yang. A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis.. Scientific reports. 2022. DOI: 10.1038/s41598-022-13527-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.